Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway
Article in Biomedicine & Pharmacotherapy (August 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (August 2024)
Article in Life (April 2024)
Article in Frontiers in Cardiovascular Medicine (October 2022)